Company to commence clinical trials of MKK4 inhi
Browsing: All news
Category Added in a WPeMatico Campaign
Predictive models offer insight into cognitive d
Vitalia CEO Niklas Anzinger on the longevity cit
Lomecel-B becomes first cell therapy to receive
Company’s ‘Immune Refresh’ approach expand
Oxford University analysis finds semaglutide doe
RF Longevity Founder Gary Arendash talks immunit
Company aims to extend female fertility window w
New insights into transcription factors and chro
If approved, HMTM would become the first oral Al